KOMBINIERTE PIZOTIPHEN- UND CINNARIZINBEHANDLUNG (PCB) BEI DER URTICARIA FACTITIA

Translated title of the contribution: Combined treatment with pizotifen and cinnarizin in urticaria factitia

I. Toth-Kasa, S. Husz

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

30 patients suffering from urticaria factitia were treated with pizotiphen and cinnarizin for 6 weeks. In 13 patients, the effect of treatment was controlled by means of the dermographism test. Placebo administration failed to affect the subjective and objective symptoms. During treatment with pizotiphen and cinnarizin, the flare significantly decreased within the first week and finally did not differ from that observed in healthy persons after 6 weeks of therapy. 19 out of 30 patients were totally free of symptoms. In 11 cases, treatment resulted in significant reduction of the urticaria, but only 7 patients still complained of itching. After repetition of the therapy, 5 patients were free of symptoms; 2 patients still reported on slight itching one year after treatment.

Original languageGerman
Pages (from-to)325-329
Number of pages5
JournalH+G Zeitschrift fur Hautkrankheiten
Volume62
Issue number4
Publication statusPublished - 1987

Fingerprint

Pizotyline
Urticaria
Pruritus
Therapeutics
Placebos

ASJC Scopus subject areas

  • Dermatology

Cite this

KOMBINIERTE PIZOTIPHEN- UND CINNARIZINBEHANDLUNG (PCB) BEI DER URTICARIA FACTITIA. / Toth-Kasa, I.; Husz, S.

In: H+G Zeitschrift fur Hautkrankheiten, Vol. 62, No. 4, 1987, p. 325-329.

Research output: Contribution to journalArticle

@article{c7caacf5286240b2acbfd1fa01b98f3e,
title = "KOMBINIERTE PIZOTIPHEN- UND CINNARIZINBEHANDLUNG (PCB) BEI DER URTICARIA FACTITIA",
abstract = "30 patients suffering from urticaria factitia were treated with pizotiphen and cinnarizin for 6 weeks. In 13 patients, the effect of treatment was controlled by means of the dermographism test. Placebo administration failed to affect the subjective and objective symptoms. During treatment with pizotiphen and cinnarizin, the flare significantly decreased within the first week and finally did not differ from that observed in healthy persons after 6 weeks of therapy. 19 out of 30 patients were totally free of symptoms. In 11 cases, treatment resulted in significant reduction of the urticaria, but only 7 patients still complained of itching. After repetition of the therapy, 5 patients were free of symptoms; 2 patients still reported on slight itching one year after treatment.",
author = "I. Toth-Kasa and S. Husz",
year = "1987",
language = "German",
volume = "62",
pages = "325--329",
journal = "JDDG - Journal of the German Society of Dermatology",
issn = "1610-0379",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - KOMBINIERTE PIZOTIPHEN- UND CINNARIZINBEHANDLUNG (PCB) BEI DER URTICARIA FACTITIA

AU - Toth-Kasa, I.

AU - Husz, S.

PY - 1987

Y1 - 1987

N2 - 30 patients suffering from urticaria factitia were treated with pizotiphen and cinnarizin for 6 weeks. In 13 patients, the effect of treatment was controlled by means of the dermographism test. Placebo administration failed to affect the subjective and objective symptoms. During treatment with pizotiphen and cinnarizin, the flare significantly decreased within the first week and finally did not differ from that observed in healthy persons after 6 weeks of therapy. 19 out of 30 patients were totally free of symptoms. In 11 cases, treatment resulted in significant reduction of the urticaria, but only 7 patients still complained of itching. After repetition of the therapy, 5 patients were free of symptoms; 2 patients still reported on slight itching one year after treatment.

AB - 30 patients suffering from urticaria factitia were treated with pizotiphen and cinnarizin for 6 weeks. In 13 patients, the effect of treatment was controlled by means of the dermographism test. Placebo administration failed to affect the subjective and objective symptoms. During treatment with pizotiphen and cinnarizin, the flare significantly decreased within the first week and finally did not differ from that observed in healthy persons after 6 weeks of therapy. 19 out of 30 patients were totally free of symptoms. In 11 cases, treatment resulted in significant reduction of the urticaria, but only 7 patients still complained of itching. After repetition of the therapy, 5 patients were free of symptoms; 2 patients still reported on slight itching one year after treatment.

UR - http://www.scopus.com/inward/record.url?scp=0023158735&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023158735&partnerID=8YFLogxK

M3 - Article

C2 - 3577293

AN - SCOPUS:0023158735

VL - 62

SP - 325

EP - 329

JO - JDDG - Journal of the German Society of Dermatology

JF - JDDG - Journal of the German Society of Dermatology

SN - 1610-0379

IS - 4

ER -